Talebian Yazdi Mehrdad, von Bartheld Martin B, Waaijenborg Femke G M, Nabers Johannes, Venmans Ben J W, Veselic-Charvat Maud, Jansen Patty M, Marijt Erik W, Annema Jouke T
J Bronchology Interv Pulmonol. 2014 Oct;21(4):298-305. doi: 10.1097/LBR.0000000000000093.
Endosonography combined with fine needle aspiration (FNA) is a minimally invasive technique for intrathoracic mediastinal nodal sampling. The value of endosonography with FNA for the diagnosis of malignant mediastinal lymphoma is under debate. In this study, the sensitivity and negative predictive value of endosonography for the assessment of primary versus recurrent malignant lymphoma were assessed.
Forty-nine patients with suspected primary (n=32) or recurrent (n=17) lymphoma were retrospectively analyzed. They presented with mediastinal nodal enlargement and underwent endosonography for diagnostic purposes between 2001 and 2011. The final diagnosis was based on surgical biopsy, conclusive cell block analysis, or longstanding clinical and radiologic follow-up.
In 33 patients, a final diagnosis of lymphoma was established; in 16 patients (33%) alternative diagnoses (eg, small cell lung cancer, sarcoidosis) were found. Sensitivity and negative predictive value of endosonography in diagnosing primary versus recurrent mediastinal lymphoma were 55% and 57% versus 88% and 90%, respectively. No complications occurred during these procedures.
On the basis of these data, we conclude that endosonography is a minimally invasive, safe, and sensitive method for the assessment of recurrent mediastinal malignant lymphoma or alternative diagnoses but has limitations in assessing a primary lymphoma diagnosis.
超声内镜联合细针穿刺抽吸术(FNA)是一种用于胸内纵隔淋巴结采样的微创技术。超声内镜联合FNA对恶性纵隔淋巴瘤诊断的价值仍存在争议。在本研究中,评估了超声内镜对原发性与复发性恶性淋巴瘤评估的敏感性和阴性预测值。
对49例疑似原发性(n = 32)或复发性(n = 17)淋巴瘤的患者进行回顾性分析。他们均表现为纵隔淋巴结肿大,并于2001年至2011年间接受了超声内镜检查以明确诊断。最终诊断基于手术活检、确定性细胞块分析或长期的临床及影像学随访。
33例患者最终确诊为淋巴瘤;16例患者(33%)发现了其他诊断(如小细胞肺癌、结节病)。超声内镜诊断原发性与复发性纵隔淋巴瘤的敏感性和阴性预测值分别为55%和57%,而对于复发性纵隔淋巴瘤分别为88%和90%。这些操作过程中未发生并发症。
基于这些数据,我们得出结论,超声内镜是评估复发性纵隔恶性淋巴瘤或其他诊断的一种微创、安全且敏感的方法,但在评估原发性淋巴瘤诊断方面存在局限性。